期刊文献+

丹红注射液中迷迭香酸、紫草酸、丹酚酸B在大鼠血浆中的浓度测定 被引量:4

Determnation of the concentrations of rosmarinic acid,lithospermic acid and salvianolic acid B in rat plasma after administration of Danhong injection
原文传递
导出
摘要 目的:建立测定大鼠血浆中丹红注射液中迷迭香酸、紫草酸、丹酚酸B浓度的方法。方法:采用HPLC法,色谱柱为Diamonsil C18柱(250 mm×4.6 mm5,μm);流动相为乙腈-0.4%的磷酸水,梯度洗脱;流速为1.0 mL.min-1;检测波长为288 nm。结果:迷迭香酸在4.0~100.0μg.mL-1浓度范围内线性关系良好(r=0.9925);回收率在85.0%~101.4%之间,日内、日间RSD<8%;紫草酸在4.0~100.0μg.mL-1浓度范围内线性关系良好(r=0.991 1);回收率在84.4%~93.9%之间,日内、日间RSD<9%;丹酚酸B在2.0~200.0μg.mL-1浓度范围内线性关系良好(r=0.998 6);回收率在80.0%~97.4%之间,日内、日间RSD<5%。结论:本文所建立的方法灵敏度好、准确率高,可用于丹红注射液中迷迭香酸、紫草酸、丹酚酸B的药代动力学研究。 Objective: To establish an HPLC method to determine the levels of rosmarinic acid,lithospermic acid and salvianolic acid B in rat plasma after iv administration of Danhong injection.Methods: In a Diamonsil C18 column,acetonitrile-0.4% phosphoric acid solution was used as the mobile phase,the flow rate was 1 mL·min-1,and detection wave length was at 288 nm.Results: Rosmarinic acid showed a good linear relationship in concentrations of 4.0~100.0 μg·mL-1(r=0.992 5);absolute recoveries were between 85.0%~101.4%;the RSD of intra-and inter-day was less than 8%.Lithospermic acid showed a good linear relationship in concentrations of 4.0~100.0 μg·mL-1;absolute recoveries were between 84.4%~93.9%;the RSD of intra-day and inter-day was less than 9%.Salvianolic acid B showed a good linear relationship in concentrations of 2.0~200.0 μg·mL-1(r=0.998 6);absolute recoveries were between 80.0%~97.4%;the RSD of intra-day and inter-day was less than 5%.Conclusion: The method is simple,quick and convenient for the pharmacokinetics of plasma rosmarinic acid,lithospermic acid and salvianolic acid B.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第24期2475-2478,共4页 Chinese Journal of New Drugs
关键词 丹红注射液 迷迭香酸 紫草酸 丹酚酸B 高效液相色谱法 Danhong injection rosmarinic acid lithospermic acid salvianolic acid B HPLC
  • 相关文献

参考文献5

二级参考文献19

  • 1邹正午,徐理纳,田金英.迷迭香酸抗血栓和抗血小板聚集作用[J].药学学报,1993,28(4):241-245. 被引量:98
  • 2张学农,唐丽华,阎雪莹,张强.紫杉醇自乳化微乳的制备及其在大鼠体内的药动学[J].中国新药与临床杂志,2005,24(4):294-298. 被引量:29
  • 3Ch.P(2005)VolⅠ(中国药典2005年版.一部)[S].2005:28-29. 被引量:7
  • 4国家药典委员会.中华人民共和国药典[S].北京:人民卫生出版社,2005:52. 被引量:7
  • 5YAO Y, WU W Y, L1U A H, et al. Interaction of salvianolic acids and notoginsengnosides in inhibition of ADP-induced platelet aggregation[J]. Am J Chin Med, 2008,36(2) :313-328. 被引量:1
  • 6Food and Dnag Administration, Centre for Drug Evaluation and Research ( CDER). Guidance for industry, Bioanalytieal method validation [ EB/OL] . May, 2001. http://www, fda. gov/eder/ guidance/4252 fnl. htm. 被引量:1
  • 7ZHOUL LIEJH.Progress review of salvianolic acid B.西部药学杂志,2007,4(4):217-217. 被引量:1
  • 8KIM C K, CHO Y J, GAO Z G. Preparation and evaluation of salvianolic acid B micro emulsions for oral delivery [J]. J Controlled Release, 2001, 70 (1-2) : 149-155. 被引量:1
  • 9TIANBP YUANZF ZHANGLT.Research overview of pharmacokinetics of salvia and its preparations.中国药房,2003,14(6):375-375. 被引量:1
  • 10KIM C K, CHO Y J, GAO Z G. Preparation and evaluation of salvianolic acid B micro emulsions for oral delivery [J].J Controlled Release, 2001, 70 ( 1-2 ) : 149-155. 被引量:1

共引文献28

同被引文献44

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部